Psyence Group Inc
CNSX:PSYG
Intrinsic Value
Psyence Group, Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. [ Read More ]
The intrinsic value of one PSYG stock under the Base Case scenario is 0.01 CAD. Compared to the current market price of 0.02 CAD, Psyence Group Inc is Overvalued by 60%.
Valuation Backtest
Psyence Group Inc
Run backtest to discover the historical profit from buying and selling PSYG stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Psyence Group Inc
Current Assets | 945.4k |
Cash & Short-Term Investments | 686.2k |
Receivables | 179.9k |
Other Current Assets | 79.3k |
Non-Current Assets | 1.1m |
PP&E | 556.1k |
Intangibles | 19.3k |
Other Non-Current Assets | 560.5k |
Current Liabilities | 1.9m |
Accounts Payable | 1.3m |
Accrued Liabilities | 616.5k |
Other Current Liabilities | 1.9k |
Non-Current Liabilities | 41k |
Long-Term Debt | 41k |
Earnings Waterfall
Psyence Group Inc
Revenue
|
5.5k
CAD
|
Operating Expenses
|
-10.3m
CAD
|
Operating Income
|
-10.3m
CAD
|
Other Expenses
|
-193.7k
CAD
|
Net Income
|
-10.5m
CAD
|
Free Cash Flow Analysis
Psyence Group Inc
PSYG Profitability Score
Profitability Due Diligence
Psyence Group Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
Score
Psyence Group Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
PSYG Solvency Score
Solvency Due Diligence
Psyence Group Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Psyence Group Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PSYG Price Targets Summary
Psyence Group Inc
Shareholder Return
PSYG Price
Psyence Group Inc
Average Annual Return | -53.45% |
Standard Deviation of Annual Returns | 18.26% |
Max Drawdown | -97% |
Market Capitalization | 2.7m CAD |
Shares Outstanding | 137 438 182 |
Percentage of Shares Shorted | 0.05% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Psyence Group, Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-01-27. The firm builds and operates commercial psilocybin cultivation and production facilities. The company offers natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences. The Company’s natural psychedelics are cultivated in Lesotho. The company focuses on the scientific research and development of psilocybin medical products for research institutions, clinics and regulatory-compliant psilocybin. The company operates across Toronto, Canada; Washington District of Columbia (DC), United States of America; Cape Town, South Africa; Kolojane, Kingdom of Lesotho; Kingston, Jamaica; London United Kingdom; Sydney, Australia and Sao Paulo, Brazil.
Contact
IPO
Employees
Officers
The intrinsic value of one PSYG stock under the Base Case scenario is 0.01 CAD.
Compared to the current market price of 0.02 CAD, Psyence Group Inc is Overvalued by 60%.